The EGFL7-ITGB3-KLF2 axis enhances survival of multiple myeloma in preclinical models.
Sign Up to like & getrecommendations! Published in 2020 at "Blood advances"
DOI: 10.1182/bloodadvances.2019001002
Abstract: Angiogenic factors play a key role in multiple myeloma (MM) growth, relapse, and drug resistance. Here we show that malignant plasma cells (cell lines and patient-derived MM cells) express angiocrine factor EGF like-7 (EGFL7) mRNA… read more here.
Keywords: multiple myeloma; itgb3 klf2; egfl7 itgb3; klf2 ... See more keywords